SAPROPTERIN DIHYDROCHLORIDE
| Brand name | KUVAN |
|---|---|
| Active ingredient | SAPROPTERIN DIHYDROCHLORIDE |
| Strength | 100MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | December 2007 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 7566462*PED | May 2026 | — |
| 8003126*PED | May 2026 | — |
| 7566462 | November 2025 | product |
| 8003126 | November 2025 | — |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.